Company News: Sidekick Launches DTx Solution for Atopic Dermatitis

Screenshot of Sidekick's Atopic Dermatitis DTx program

May 23, 2022

reviewed by

As part of the growing relationship between Sidekick Health and Pfizer, the two companies are rolling out their integrated digital therapeutics offering for atopic dermatitis in 24 markets by 2024 – starting with the UK. This expanded offering builds upon a collaboration that was established in June 2020.

‍

BERLIN, BOSTON, REYKJAVIK, 19 May 2022 – International digital therapeutics innovator, Sidekick Health, today announces the launch of an integrated digital therapeutics solution for improving the outcomes of patients with Atopic Dermatitis (AD) in conjunction with Pfizer Inc., one of the world’s premier innovative biopharmaceutical companies. Sidekick and Pfizer will be rolling out their integrated digital therapeutics offering, launching first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. This marks the next phase of a growing relationship to develop digital patient support programs globally, including expansion into 24 markets by 2024.

‍

The Challenge of Living with Atopic Dermatitis

AD is an inﬂammatory, pruritic, chronic, or chronically relapsing skin disease that affects up to 14% of adults worldwide. People living with moderate to severe AD often have to deal with constant and relentless itching, leading to sleep deprivation, increased stress and anxiety that affects the quality of their lives.

‍

However, one of the challenges of effectively treating AD is that patients’ adherence to treatment tends to be low. Sidekick’s digital therapeutics platform addresses this using gamification principles, behavioral economics, and artificial intelligence (AI) to deliver treatment through dynamic care pathways that help inspire lasting behavioral change, positively impacting health outcomes.

‍

By reducing stress, improving sleep quality, and promoting other lifestyle factors designed to improve the quality of life for people living with AD, Sidekick’s digital patient support program has demonstrated the potential to make a meaningful impact. A recent feasibility study showed medication adherence had increased in 83% of patients using the app to manage their chronic illnesses.

“We are extremely excited to be entering the next phase in our ongoing relationship with Pfizer,” comments Dr. Tryggvi Thorgeirsson, CEO and Co-Founder of Sidekick. “At Sidekick, it’s always been our ambition to help as many people as possible to make long-lasting improvements to lifestyle behaviors and improve their quality of life. Our work with Pfizer better enables us to reach our goal of bringing digital therapeutics into the homes of people around the world.”

Want to learn more about implementing digital-first health solutions?

Ana Paula Carvalho, Regional President, International Developed Markets, Inflammation & Immunology at Pfizer highlighted that “Autoimmune and chronic inflammatory diseases such as atopic dermatitis can be debilitating, disfiguring, and distressing, dramatically affecting what people living with the disease can do.

‍

At Pfizer, we recognize patient care goes beyond medical advances and we are proud to be working with Sidekick to put their technology in the hands of people who need it most. A holistic approach to treating the individual, not just the disease, is essential in order to advance the standard of care for patients and to empower them to live their best lives.”

‍

About Sidekick

Sidekick is a digital therapeutics innovator, founded by two passionate medical doctors on a mission to improve the health of humanity. Sidekick is driven by a vision to bring healthcare into people’s everyday lives, empowering them to take control of their own health. Sidekick’s therapeutics are developed and delivered with digital technology, addressing the same endpoints as effectively as traditional treatments – such as small molecule drugs and biologics, but with the added benefit of giving people the opportunity to be actively involved in their own treatment.

‍

When combined with traditional treatments, the overall efficacy is strongly increased. The Sidekick digital platform is proven to help patients to manage the discomfort of living with a chronic illness, including tools to manage stress, guides for healthy eating, and mindfulness tools, as well as hours of video content and educational cards to improve health literacy and educate patients on the day-to-day aspects of living with a chronic disease. That is why Sidekick partners with the world’s most innovative companies across the healthcare spectrum.

‍

Let's keep you informed about developments in the digital therapeutics space. Sign-up for The Sidebar now. (Don’t worry, you can unsubscribe at any time.)